Literature DB >> 16394370

Bullous systemic lupus erythematosus: response to dapsone in two patients.

C S Sirka, T Padhi, P Mohanty, D K Patel, P R Parida, C R Kar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16394370     DOI： 10.4103/0378-6323.13795

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  6 in total

Review 1.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

2.  Bullous lesions as a manifestation of systemic lupus erythematosus in two Mexican teenagers.

Authors:  Marimar Sáez-de-Ocariz; Francisco Espinosa-Rosales; Eduardo López-Corella; Beatriz de León-Bojorge
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

Review 3.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

Review 4.  Treatment of Bullous Systemic Lupus Erythematosus.

Authors:  Lihua Duan; Liying Chen; Shan Zhong; Ying Wang; Yan Huang; Yan He; Jie Chen; Guixiu Shi
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

5.  Vesiculobullous diseases in relation to lupus erythematosus.

Authors:  Suthinee Rutnin; Kumutnart Chanprapaph
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-04

6.  Clinicopathological and Immunological Profile of Patients with Cutaneous Manifestations and their Relationship with Organ Involvement in Systemic Lupus Erythematosus Attending a Tertiary Care Center of Eastern India.

Authors:  Arghya P Ghosh; Falguni Nag; Saugato Biswas; Raghavendra Rao; Abhishek De
Journal:  Indian J Dermatol       Date:  2020 Jan-Feb       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.